T2 Biosystems Incの簿価
T2 Biosystems Incの簿価 は何ですか。
T2 Biosystems Incの簿価 は-6.20です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるT2 Biosystems Inc
T2 Biosystems Incは何をしますか。
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Incと類似の簿価
- Novavaxの簿価 は-6.51です。
- American Airlines Incの簿価 は-6.46です。
- Vector Ltdの簿価 は-6.37です。
- Dine Brands Global Incの簿価 は-6.36です。
- Mettler-Toledo Internationalの簿価 は-6.33です。
- Harte Hanksの簿価 は-6.26です。
- T2 Biosystems Incの簿価 は-6.20です。
- i-nexus Global plcの簿価 は-6.20です。
- Lowe's Companiesの簿価 は-6.17です。
- Wyndham Destinations Incの簿価 は-6.17です。
- Quantum Corpの簿価 は-6.15です。
- Simbhaoli Sugarsの簿価 は-6.12です。
- Bridgemarq Real Estate Servicesの簿価 は-6.08です。